187 related articles for article (PubMed ID: 35880842)
1. The effects of the interactions of STAT4 rs7574865 with HBV mutations on the risk of hepatocellular carcinoma.
Yang C; Chen H; Zhou B; Yin J; Cao G; Hou J; Jiang D
Mol Carcinog; 2022 Oct; 61(10):933-940. PubMed ID: 35880842
[TBL] [Abstract][Full Text] [Related]
2. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis.
Jiang DK; Ma XP; Wu X; Peng L; Yin J; Dan Y; Huang HX; Ding DL; Zhang LY; Shi Z; Zhang P; Yu H; Sun J; Lilly Zheng S; Deng G; Xu J; Liu Y; Guo J; Cao G; Yu L
Sci Rep; 2015 Nov; 5():16278. PubMed ID: 26538132
[TBL] [Abstract][Full Text] [Related]
4. Association of
Shi H; He H; Ojha SC; Sun C; Fu J; Yan M; Deng C; Sheng Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160486
[No Abstract] [Full Text] [Related]
5. A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B.
El Sharkawy R; Thabet K; Lampertico P; Petta S; Mangia A; Berg T; Metwally M; Bayoumi A; Boonstra A; Brouwer WP; Smedile A; Abate ML; Loglio A; Douglas MW; Khan A; Santoro R; Fischer J; Leeming DJ; Liddle C; George J; Eslam M
Aliment Pharmacol Ther; 2018 Sep; 48(5):564-573. PubMed ID: 29963713
[TBL] [Abstract][Full Text] [Related]
6. Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
Chanthra N; Payungporn S; Chuaypen N; Piratanantatavorn K; Pinjaroen N; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(18):8405-10. PubMed ID: 26745093
[TBL] [Abstract][Full Text] [Related]
7. A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma.
Clark A; Gerlach F; Tong Hv; Hoan NX; Song le H; Toan NL; Bock CT; Kremsner PG; Velavan TP
Infect Genet Evol; 2013 Aug; 18():257-61. PubMed ID: 23748017
[TBL] [Abstract][Full Text] [Related]
8. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population.
Kim LH; Cheong HS; Namgoong S; Kim JO; Kim JH; Park BL; Cho SW; Park NH; Cheong JY; Koh I; Shin HD; Kim YJ
Infect Genet Evol; 2015 Jul; 33():72-6. PubMed ID: 25913043
[TBL] [Abstract][Full Text] [Related]
9. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.
Xie J; Zhang Y; Zhang Q; Han Y; Yin J; Pu R; Shen Q; Lu W; Du Y; Zhao J; Han X; Zhang H; Cao G
Hepatology; 2013 Jun; 57(6):2369-77. PubMed ID: 23386590
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
Zhao Y; Chen K; Yang H; Zhang F; Ding L; Liu Y; Zhang L; Zhang Y; Wang H; Deng Y
Virol J; 2023 Nov; 20(1):283. PubMed ID: 38037048
[TBL] [Abstract][Full Text] [Related]
11. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in STAT4 predicts response to interferon-α therapy for hepatitis B e antigen-positive chronic hepatitis B.
Jiang DK; Wu X; Qian J; Ma XP; Yang J; Li Z; Wang R; Sun L; Liu F; Zhang P; Zhu X; Wu J; Chen K; Conran C; Zheng SL; Lu D; Yu L; Liu Y; Xu J
Hepatology; 2016 Apr; 63(4):1102-11. PubMed ID: 26704347
[TBL] [Abstract][Full Text] [Related]
13. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.
Zhang Q; Yin J; Zhang Y; Deng Y; Ji X; Du Y; Pu R; Han Y; Zhao J; Han X; Zhang H; Cao G
J Virol; 2013 Nov; 87(22):12176-86. PubMed ID: 24006435
[TBL] [Abstract][Full Text] [Related]
14. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
[TBL] [Abstract][Full Text] [Related]
15. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
Song XM; Li QL; Guo F; Peng H; Guo JJ
Ann Hepatol; 2018 Oct; 17(6):940-947. PubMed ID: 30600290
[TBL] [Abstract][Full Text] [Related]
16. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
[No Abstract] [Full Text] [Related]
17. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
Jiang DK; Sun J; Cao G; Liu Y; Lin D; Gao YZ; Ren WH; Long XD; Zhang H; Ma XP; Wang Z; Jiang W; Chen TY; Gao Y; Sun LD; Long JR; Huang HX; Wang D; Yu H; Zhang P; Tang LS; Peng B; Cai H; Liu TT; Zhou P; Liu F; Lin X; Tao S; Wan B; Sai-Yin HX; Qin LX; Yin J; Liu L; Wu C; Pei Y; Zhou YF; Zhai Y; Lu PX; Tan A; Zuo XB; Fan J; Chang J; Gu X; Wang NJ; Li Y; Liu YK; Zhai K; Zhang H; Hu Z; Liu J; Yi Q; Xiang Y; Shi R; Ding Q; Zheng W; Shu XO; Mo Z; Shugart YY; Zhang XJ; Zhou G; Shen H; Zheng SL; Xu J; Yu L
Nat Genet; 2013 Jan; 45(1):72-5. PubMed ID: 23242368
[TBL] [Abstract][Full Text] [Related]
18. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
19. The association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population.
Ma L; Chen S; Mao X; Lu Y; Zhang X; Lao X; Qin X; Li S
Sci Rep; 2018 Jun; 8(1):9240. PubMed ID: 29915336
[TBL] [Abstract][Full Text] [Related]
20. Stat4 rs7574865 polymorphism promotes the occurrence and progression of hepatocellular carcinoma via the Stat4/CYP2E1/FGL2 pathway.
Wang C; Gao N; Yang L; Guo Y; Fang Y; Wang T; Xu C; Li GF; Zhou J; Zhang Y; Wen Q; Qiao H
Cell Death Dis; 2022 Feb; 13(2):130. PubMed ID: 35136014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
